I, JULIANNE QUAINE, Assistant Secretary, Pharmaceutical Access Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Amendment Instrument under subsections 100(1) and 100(2) of the National Health Act 1953.

Dated   26 November 2015

Julianne Quaine

Assistant Secretary

Pharmaceutical Access Branch

Pharmaceutical Benefits Division

Department of Health

_____________________________________________________________________

1 Name of Instrument

(1) This Instrument is the National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2015 (No.1).

(2) This Instrument may also be cited as PB 96 of 2015.

2 Commencement

(1) This instrument commences on 1 December 2015.

3 Amendment of PB 85 of 2015

Schedule 1 amends the National Health (Growth Hormone Program) Special Arrangement 2015 (PB 85 of 2015).

Schedule 1 Amendments

[1] Schedule 1, after the entry for the listed drug Somatropin, in the form Solution for injection 5 mg (15 i.u.) in 1.5 mL cartridge (with preservative), with the manner of administration of Injection, and Brand Omintrope

insert:

[2] Schedule 1, after the entry for the listed drug Somatropin, in the form Solution for injection 10 mg (30 i.u.) in 1.5 mL cartridge (with preservative), with the manner of administration of Injection, and Brand Omnitrope

insert:

[3] Schedule 1, entry for the listed drug Somatropin, in the form Solution for injection 15 mg (45 i.u) in 1.5 mL cartridge (with preservative), with the manner of administration of Injection

a) omit from the column headed ‘Brand’: Omnitrope SurePal

b) insert in the column headed ‘Brand’: Omnitrope Surepal 15